Companies in Latin America's Pharmaceutical & Biotech Industry have delayed the authorizations for expenditure on 93 capital-spending projects, with a total investment value of more than $245 million, during the second quarter of 2020. This period has seen a tightening of lockdowns and restrictions related to the COVID-19 pandemic.
(All Fields Required)
Site-wide Scheduled Maintenance for April 12, 2025, between 9 A.M. - 9 P.M. CST. During this time, all services will be unavailable periodically throughout the scheduled maintenance window.
×Contact Us
For More Info!